Affinity maturation of phage display antibody populations using ribosome display

被引:50
作者
Groves, Maria [1 ]
Lane, Steven [1 ]
Douthwaite, Julie [1 ]
Lowne, David [1 ]
Rees, D. Gareth [1 ]
Edwards, Bryan [1 ]
Jackson, Ronald H. [1 ]
机构
[1] Cambridge Antibody Technol, Cambridge CB1 6GH, England
关键词
phage display; ribosome display; antibody; insulin;
D O I
10.1016/j.jim.2006.04.002
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A comparison has been performed, using phage display or ribosome display, of stringent selections on antibody populations derived from three rounds of phage display selection. Stringent selections were performed by reducing concentrations of the antigen, bovine insulin, down to 1 nM. Higher affinity antibodies were isolated using ribosome display in a process that introduces random mutations across the clone population. Whereas the highest affinity antibody produced by phage display, D3, has a K-d of 5.8 nM as a scFv fragment, ribosome display generated higher affinity variants of this antibody with Kd values of 189 pM and 152 pM, without or with the use of error prone mutagenesis, respectively. The affinities were further increased for each antibody on conversion of the scFv fragments to whole IgG format, to a K-d of less than 21 pM for the highest affinity variant of D3. Mutation of VH D101 of antibody D3 to glycine or valine, removing the salt bridge between K94 and D101 at the base of VHCDR3, was responsible for the enhanced affinity observed. In addition to the variants of D3, other unrelated antibodies of comparable or higher affinity for insulin, were isolated by ribosome display, but not phage display, indicating that ribosome display can enrich for different populations of antibodies. Affinity maturation of phage antibody populations using ribosome display is a valuable method of rapidly generating diverse, high affinity antibodies to antigen and should be readily applicable to the isolation of antibodies for the detection and assay of biomarkers. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:129 / 139
页数:11
相关论文
共 36 条
[32]   A fully human antibody neutralising biologically active human TGFβ2 for use in therapy [J].
Thompson, JE ;
Vaughan, TJ ;
Williams, AJ ;
Wilton, J ;
Johnson, KS ;
Bacon, L ;
Green, JA ;
Field, R ;
Ruddock, S ;
Martins, M ;
Pope, AR ;
Tempest, PR ;
Jackson, RH .
JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 227 (1-2) :17-29
[33]   THE REPERTOIRE OF HUMAN GERMLINE V(H) SEQUENCES REVEALS ABOUT 50 GROUPS OF V(H) SEGMENTS WITH DIFFERENT HYPERVARIABLE LOOPS [J].
TOMLINSON, IM ;
WALTER, G ;
MARKS, JD ;
LLEWELYN, MB ;
WINTER, G .
JOURNAL OF MOLECULAR BIOLOGY, 1992, 227 (03) :776-798
[34]   CDR WALKING MUTAGENESIS FOR THE AFFINITY MATURATION OF A POTENT HUMAN ANTI-HIV-1 ANTIBODY INTO THE PICOMOLAR RANGE [J].
YANG, WP ;
GREEN, K ;
PINZSWEENEY, S ;
BRIONES, AT ;
BURTON, DR ;
BARBAS, CF .
JOURNAL OF MOLECULAR BIOLOGY, 1995, 254 (03) :392-403
[35]   Selection of hapten-specific single-domain antibodies from a non-immunized llama ribosome display library [J].
Yau, KYF ;
Groves, MAT ;
Li, SH ;
Sheedy, C ;
Lee, H ;
Tanha, J ;
MacKenzie, CR ;
Jermutus, L ;
Hall, JC .
JOURNAL OF IMMUNOLOGICAL METHODS, 2003, 281 (1-2) :161-175
[36]   Directed in vitro evolution and crystallographic analysis of a peptide-binding single chain antibody fragment (scFv) with low picomolar affinity [J].
Zahnd, C ;
Spinelli, S ;
Luginbühl, B ;
Amstutz, P ;
Cambillau, C ;
Plückthun, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (18) :18870-18877